Monsanto (MON) Signs Deal With ToolGen For CRISPR Technology
Zacks Investment Research | Aug 16, 2017 10:15PM ET
Monsanto Company (NYSE:MON) recently inked a global licensing agreement with ToolGen, Inc. (ToolGen), for an undisclosed amount. The deal, which is based on ToolGen’s CRISPR technology, is anticipated to help Monsanto innovate state-of-the-art crop-yield enhancing solutions for farmers.
ToolGen is a biotechnology company primarily focused on developing non-imitable genome editing technologies like CRISPR. Cultivators seek diverse seed choices for maximizing their crop yield and minimizing resource utilization. Hence, agricultural solutions, which help farmers deal with the changing climatic conditions, combat pests and plant diseases, as well as provide guidance for optimal resource deployment, have been enjoying high demand, of late. Agricultural researchers develop such solutions with the support of genome-editing technologies.
Per the latest deal, Monsanto will secure the complete set of intellectual property rights against ToolGen’s CRISPR genome-editing technology. The company noted that this move will likely diversify and fortify its presence in the agricultural research segment. It will further enhance Monsanto’s genome-editing tools portfolio which is used to develop sustainable and improved crops.
Existing Scenario
There is an ongoing trend of consolidation in the contemporary seed, trails and agricultural chemical industry. While E. I. du Pont de Nemours and Company (NYSE:DD) and The Dow Chemical Company (NYSE:DOW) inked a $140-million merger deal (likely to close on Aug 31, 2017), ChemChina successfully acquired Syngenta AG (NYSE:SYT) for $43 billion (closed on Jun 28, 2017). This drift has been making matters worse for Monsanto and increasing competitive pressure for the company. In addition, dismal pricing conditions in the agricultural market and foreign currency translation impact remain major causes of concern.
However, increasing demand for crop-yield enhancing products, strong innovation and the success of Bayer AG’s (OTC:BAYRY) buyout deal, likely to close by the end of this year, are anticipated to bolster Monsanto’s top- and bottom-line performance in the quarters ahead.
Over the last month, shares of this Zacks Rank #3 (Hold) stock yielded a return of 0.88%, as against 0.05% loss incurred by the Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.